Physicians are Unwinding the Secret of COVID 19

Medical Professionals are Deciphering the Mystery of COVID 19

There is NEW evidence to recommend that COVID 19 is causing the body to make antibodies that attack itself.

COVID 19 is strange in a great deal of ways, despite us already knowing a lot about it. Researchers & physicians are working hard to decipher the domino effect of the interaction in between the SARS-CoV-2 infection and the immune system. COVID triggers numerous symptoms that may point to a phenomenon called autoimmunity as a possible cause of long COVID. This includes pulmonary fibrosis, indicating scarring of the lungs. Unfortunately, I’m seeing the very same photo unfold in so many of my clients who have actually had COVID, with all this scarring in their lungs. And COVID can trigger other issues, like brain modifications, skin rashes, excessive blood clot, inflamed capillary, and more.

There are lots of auto-immune conditions that can cause scarring in the lungs, like lupus, rheumatoid arthritis, scleroderma, polymyositis, ankylosing spondylitis, and more– the proof to support the function of autoantibodies as a cause of more extreme COVID19 The huge bulk of people who get COVID 19 will have an illness separated to the upper respiratory tract. In 20 percent of people, the infection will go deep into the lung parenchyma and have the potential to trigger more serious illness, meaning COVID pneumonia, which sometimes blossoms into ARDS.
Autoimmunity as a potential reason for more severe COVID 19 disease was brought up when autopsies. Cytokine storms are an overreaction by the body immune system and are more systemic and short-term. In contrast, autoantibodies are more targeted and long-lasting. Dexamethasone, a corticosteroid, and the arthritis drugs tocilizumab and sarilumab have been utilized to regulate an overactive immune response. In a medical trial, tocilizumab and sarilumab enhanced critically ill patients’ results on a ventilator in the extensive care unit.
A study at Rockefeller University in New York enrolled nearly a thousand people with extreme COVID19 This data will be compared to the circulation and portion of each aspect in individuals with severe COVID19
.
Researchers in another research study supported the finding of increased autoantibodies in COVID patients. The antibodies they found were directed towards B cells, a kind of immune cell that produces antibodies and interferon. Although the researchers noted no “COVID 19 particular” autoantibodies that distinguish COVID clients from uninfected controls, the levels of autoantibodies were correlated with recognized markers for inflammation. The correlations became more severe as the illness aggravated. These medications require mindful timing to interrupt an overreactive body immune system without hindering a regular body immune system combating the COVID 19 infection. COVID 19 is typically a biphasic health problem with an initial stage, mostly respiratory symptoms triggered by the virus and the instant immune action, with natural resistance. In some cases, it is followed by a secondary inflammatory stage.

There are two body immune system arms, the non-specific inherent body immune system and the specific adaptive immune system. Whenever you are infected with a pathogen that is brand-new to your body immune system, you depend on the innate body immune system to combat the pathogen. Interferons are important to the natural reaction. Interferon-β is one of the first cytokines produced and drives the innate immune reaction in the lung. This connection shows the significance of the finding that SARS-CoV-2 might inhibit interferon activity in those who establish more severe COVID 19.

Medical Professional Mike Hansen, MD
Internal Medication|Lung Disease|Crucial Care Medication

#covid #covid19

https://covid19globalcases.com/physicians-are-unwinding-the-secret-of-covid-19/